Astal Laboratories Limited (BOM:512600)
58.67
-0.44 (-0.74%)
At close: Nov 20, 2026
Astal Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2.52 | 7.03 | 17.3 | 60.77 | 0.84 | 0.18 |
Long-Term Investments | - | 34.36 | 20.65 | - | - | - |
Loans & Lease Receivables | 38.98 | 41.49 | 40.93 | 39.93 | 37.88 | 51.12 |
Other Receivables | 1,597 | 1,570 | 276.64 | 158.15 | 31.87 | - |
Property, Plant & Equipment | 627.4 | 630.91 | 114.44 | 6.9 | 0.06 | 0.14 |
Goodwill | - | 2,032 | - | - | - | - |
Other Intangible Assets | 2,032 | 13.69 | - | - | - | - |
Other Current Assets | 140.68 | 179.18 | 14.85 | 37.79 | 28.43 | 0.79 |
Long-Term Deferred Tax Assets | - | - | - | - | 0.01 | 0.07 |
Other Long-Term Assets | 41.86 | 3.97 | 1 | 52.03 | - | - |
Total Assets | 5,474 | 5,187 | 633.41 | 366.13 | 99.08 | 52.29 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1,218 | 1,244 | 107.75 | 115.15 | 37.93 | - |
Accrued Expenses | - | 21.07 | 0.41 | 0.55 | 0.42 | - |
Short-Term Debt | - | 289.66 | 126.94 | - | - | - |
Current Portion of Long-Term Debt | 332.85 | 14.76 | 1.18 | 0.55 | - | - |
Current Portion of Leases | 1.62 | 1.62 | - | - | - | - |
Long-Term Debt | 191.24 | 186.42 | 4.56 | 2.57 | - | - |
Long-Term Leases | 5.67 | 6.48 | - | - | - | - |
Current Income Taxes Payable | - | 72.37 | 31.31 | 3.82 | - | - |
Other Current Liabilities | 138.59 | 5.34 | 0.12 | 10.03 | 8.96 | 0.69 |
Long-Term Deferred Tax Liabilities | 11.46 | 8.62 | 1.19 | 0.07 | - | - |
Other Long-Term Liabilities | - | -0 | - | - | - | 0 |
Total Liabilities | 1,900 | 1,850 | 273.46 | 132.74 | 47.31 | 0.69 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 438.15 | 422.16 | 98.3 | 98.3 | 39.74 | 39.74 |
Additional Paid-In Capital | - | 2,638 | 115.22 | 115.22 | - | - |
Retained Earnings | - | 254.14 | 107.05 | 17.79 | 9.95 | 9.78 |
Comprehensive Income & Other | 3,136 | 22.78 | 39.38 | 2.08 | 2.08 | 2.08 |
Shareholders' Equity | 3,574 | 3,338 | 359.95 | 233.4 | 51.77 | 51.6 |
Total Liabilities & Equity | 5,474 | 5,187 | 633.41 | 366.13 | 99.08 | 52.29 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 531.38 | 498.92 | 132.68 | 3.12 | - | - |
Net Cash (Debt) | -528.87 | -491.9 | -115.38 | 57.64 | 0.84 | 0.18 |
Net Cash Growth | - | - | - | 6729.74% | 361.20% | -41.52% |
Net Cash Per Share | -15.51 | -26.12 | -10.39 | 11.41 | 0.21 | 0.05 |
Filing Date Shares Outstanding | 43.79 | 42.22 | 9.83 | 9.83 | 3.97 | 3.97 |
Total Common Shares Outstanding | 43.79 | 42.22 | 9.83 | 9.83 | 3.97 | 3.97 |
Working Capital | 1,081 | 824.15 | 229.61 | 177.12 | 51.7 | 51.4 |
Book Value Per Share | 81.61 | 79.06 | 36.62 | 23.74 | 13.03 | 12.98 |
Tangible Book Value | 1,542 | 1,292 | 359.95 | 233.4 | 51.77 | 51.6 |
Tangible Book Value Per Share | 35.21 | 30.60 | 36.62 | 23.74 | 13.03 | 12.98 |